Related Experiment Video
Updated: Jun 17, 2025
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Serum inflammatory markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for mycoplasma
Li-Ping Wang1, Zhong-Hua Hu1, Jun-Sheng Jiang1
1Department of Pediatrics, The First People's Hospital of Linping District, Hangzhou 310000, Zhejiang Province, China.
Background:
Mycoplasma pneumoniae pneumonia (MPP) significantly impacts pediatric health, necessitating markers for early severe disease identification.
Aim:
To investigate the correlation between serum inflammatory marker and the severity of MPP in children.
Methods:
A prospective study was carried out from January 2023 to November 2023. A total of 160 children with MPP who underwent treatment were selected: 80 had severe MPP and 80 had mild MPP. Clinical and laboratory data were collected at the time of hospital admission and during hospitalization. Receiver operating characteristic curves were utilized to assess the diagnostic and prognostic for severe MPP.
Results:
Fever duration and length of hospitalization in pediatric patients with severe MPP exceeded those with mild MPP. The incidence of pleural effusion, lung consolidation, and bronchopneumonia on imaging was markedly elevated in the severe MPP cohort compared to the mild MPP cohort. In contrast to the mild cohort, there was a notable increase in C-reactive protein (CRP), procalcitonin (PCT), erythrocyte sedimentation rate, lactic dehydrogenase, D-dimer, and inflammatory cytokines [interleukin (IL)-6, IL-8, IL-10 and tumor necrosis factor (TNF)-α] in the severe MPP group were significantly higher.
Conclusion:
Serum inflammatory markers (CRP, PCT, IL-6, D-dimer, IL-10 and TNF-α) were considered as predictors in children with severe MPP.
Insights
Serum inflammatory markers like C-reactive protein (CRP) and interleukin-6 (IL-6) can predict severe pediatric pneumonia. These markers aid in early identification of severe Mycoplasma pneumoniae pneumonia (MPP) in children.
Area of Science:
- Pediatric Infectious Diseases
- Respiratory Medicine
- Clinical Immunology
Background:
- Mycoplasma pneumoniae pneumonia (MPP) poses a significant threat to child health.
- Early identification of severe MPP cases is crucial for timely intervention.
- Existing diagnostic methods may not sufficiently predict disease severity.
Purpose of the Study:
- To determine the association between serum inflammatory markers and MPP severity in children.
- To evaluate the predictive value of specific inflammatory markers for severe MPP.
- To identify potential biomarkers for early detection of severe pediatric pneumonia.
Main Methods:
- A prospective study involving 160 children with MPP (80 severe, 80 mild) was conducted.
- Clinical and laboratory data were collected during hospitalization.
- Receiver operating characteristic (ROC) curves were used to assess diagnostic and prognostic capabilities for severe MPP.
Main Results:
- Severe MPP cases exhibited longer fever duration and hospitalization than mild cases.
- Imaging revealed higher rates of pleural effusion, lung consolidation, and bronchopneumonia in severe MPP.
- Elevated levels of CRP, PCT, ESR, LDH, D-dimer, IL-6, IL-8, IL-10, and TNF-α were observed in severe MPP patients.
Conclusions:
- Serum inflammatory markers including CRP, PCT, IL-6, D-dimer, IL-10, and TNF-α are significant predictors of severe MPP in children.
- These markers show potential for early identification and risk stratification of pediatric pneumonia.
- Further research can validate these findings for clinical application in pediatric respiratory infections.
